Company Filing History:
Years Active: 2011-2012
Title: Melissa A Smith: Innovator in Pharmacogenomics
Introduction
Melissa A Smith is a prominent inventor based in Hampshire, GB. She has made significant contributions to the field of pharmacogenomics, particularly in the context of drug therapy for immune-mediated gastrointestinal disorders. With a total of 2 patents, her work focuses on optimizing therapeutic efficacy and predicting patient tolerance to specific medications.
Latest Patents
One of her latest patents is titled "Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy." This invention provides methods for predicting tolerance associated with 6-mercaptopurine drug treatment of conditions such as inflammatory bowel disease. The patent outlines methods for assessing a patient's risk of adverse drug reactions by genotyping specific genes, including xanthine dehydrogenase (XDH), molybdenum cofactor sulfurase (MOCOS), and aldehyde oxidase (AOX). Furthermore, it offers strategies for determining whether a patient should be prescribed an alternative drug based on genetic polymorphisms.
Career Highlights
Melissa A Smith is affiliated with Guy's and St. Thomas' NHS Foundation Trust, where she continues to advance her research and innovations. Her work has been instrumental in enhancing the understanding of drug interactions and patient-specific responses to therapies.
Collaborations
Some of her notable coworkers include Jeremy D Sanderson and Anthony M Marinaki, who contribute to her research endeavors and collaborative projects.
Conclusion
Melissa A Smith's innovative work in pharmacogenomics exemplifies the importance of personalized medicine in improving patient outcomes. Her patents reflect a commitment to advancing healthcare through scientific research and innovation.